Xian‐Da Yang

1.5k total citations
27 papers, 1.2k citations indexed

About

Xian‐Da Yang is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Xian‐Da Yang has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Biomedical Engineering and 8 papers in Biomaterials. Recurrent topics in Xian‐Da Yang's work include Advanced biosensing and bioanalysis techniques (13 papers), RNA Interference and Gene Delivery (11 papers) and Nanoparticle-Based Drug Delivery (8 papers). Xian‐Da Yang is often cited by papers focused on Advanced biosensing and bioanalysis techniques (13 papers), RNA Interference and Gene Delivery (11 papers) and Nanoparticle-Based Drug Delivery (8 papers). Xian‐Da Yang collaborates with scholars based in China, United Kingdom and United States. Xian‐Da Yang's co-authors include Jinhong Duan, Yan Hu, Haiyan Xu, Xin Lu, Chen Wang, Jie Meng, Xundou Li, Wei Liang, Chen Wang and Chenchen Yu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Small.

In The Last Decade

Xian‐Da Yang

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xian‐Da Yang China 16 848 417 311 179 130 27 1.2k
Xujuan Yang United States 14 513 0.6× 517 1.2× 495 1.6× 187 1.0× 119 0.9× 15 1.2k
Sriram S. Shanmugavelandy United States 17 542 0.6× 363 0.9× 210 0.7× 165 0.9× 94 0.7× 21 1.0k
Larissa Yokota Rizzo Germany 13 286 0.3× 382 0.9× 335 1.1× 166 0.9× 88 0.7× 15 953
Jan‐Niklas May Germany 7 363 0.4× 623 1.5× 536 1.7× 156 0.9× 133 1.0× 11 1.1k
Zhihao Han China 17 470 0.6× 393 0.9× 172 0.6× 202 1.1× 78 0.6× 54 954
Malathi Anantha Canada 19 550 0.6× 292 0.7× 518 1.7× 86 0.5× 194 1.5× 37 1.0k
Jonathan P. May Canada 17 356 0.4× 501 1.2× 392 1.3× 118 0.7× 52 0.4× 32 936
Jungshan Chang Taiwan 19 386 0.5× 200 0.5× 135 0.4× 138 0.8× 223 1.7× 50 909
Qi Lu China 15 472 0.6× 327 0.8× 179 0.6× 104 0.6× 148 1.1× 28 853
Daniela Fraier United Kingdom 14 496 0.6× 319 0.8× 565 1.8× 62 0.3× 220 1.7× 27 1.2k

Countries citing papers authored by Xian‐Da Yang

Since Specialization
Citations

This map shows the geographic impact of Xian‐Da Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xian‐Da Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xian‐Da Yang more than expected).

Fields of papers citing papers by Xian‐Da Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xian‐Da Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xian‐Da Yang. The network helps show where Xian‐Da Yang may publish in the future.

Co-authorship network of co-authors of Xian‐Da Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xian‐Da Yang. A scholar is included among the top collaborators of Xian‐Da Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xian‐Da Yang. Xian‐Da Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xundou, et al.. (2024). Novel nanotherapeutics for cancer immunotherapy by albumin nanoparticles functionalized with PD-1 and PD-L1 aptamers. Cancer Nanotechnology. 15(1). 9 indexed citations
2.
3.
Li, Xundou, et al.. (2023). Novel nanotherapeutics for cancer immunotherapy by CTLA-4 aptamer-functionalized albumin nanoparticle loaded with antihistamine. Journal of Cancer Research and Clinical Oncology. 149(10). 7515–7527. 9 indexed citations
4.
Li, Xundou, et al.. (2020). <p>Targeted Treatment of Colon Cancer with Aptamer-Guided Albumin Nanoparticles Loaded with Docetaxel</p>. International Journal of Nanomedicine. Volume 15. 6737–6748. 57 indexed citations
5.
Li, Xundou, et al.. (2020). <p>Targeted Therapy of Colon Cancer by Aptamer-Guided Holliday Junctions Loaded with Doxorubicin</p>. International Journal of Nanomedicine. Volume 15. 2119–2129. 32 indexed citations
6.
Hu, Yan, et al.. (2019). Selection of a novel DNA aptamer against OFA/iLRP for targeted delivery of doxorubicin to AML cells. Scientific Reports. 9(1). 7343–7343. 14 indexed citations
7.
8.
Hu, Yan, et al.. (2016). Aptamer-guided DNA tetrahedron as a novel targeted drug delivery system for MUC1-expressing breast cancer cells in vitro. Oncotarget. 7(25). 38257–38269. 67 indexed citations
9.
Yang, Xian‐Da, et al.. (2014). Lifestyle risks exposure and response predictor of gefitinib in patients with non-small cell lung cancer. Medical Oncology. 31(10). 220–220. 8 indexed citations
10.
Wang, Wei, Zhongjun Li, Jinhong Duan, et al.. (2014). In vitro enhancement of dendritic cell-mediated anti-glioma immune response by graphene oxide. Nanoscale Research Letters. 9(1). 311–311. 25 indexed citations
11.
Hu, Yan, et al.. (2014). Selection of a Novel DNA Aptamer for Assay of Intracellular Interferon-Gamma. PLoS ONE. 9(5). e98214–e98214. 23 indexed citations
12.
Chang, Tianjun, Qi Cui, Jie Meng, et al.. (2013). General Cell-Binding Activity of Intramolecular G-Quadruplexes with Parallel Structure. PLoS ONE. 8(4). e62348–e62348. 28 indexed citations
13.
Meng, Jie, Xian‐Da Yang, Lee Jia, Xing‐Jie Liang, & Chen Wang. (2012). Impacts of Nanoparticles on Cardiovascular Diseases: Modulating Metabolism and Function of Endothelial Cells. Current Drug Metabolism. 13(8). 1123–1129. 13 indexed citations
14.
Hu, Yan, et al.. (2012). Novel MUC1 Aptamer Selectively Delivers Cytotoxic Agent to Cancer Cells In Vitro. PLoS ONE. 7(2). e31970–e31970. 130 indexed citations
15.
Liu, Zhe, Jinhong Duan, Yongmei Song, et al.. (2012). Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro. Journal of Translational Medicine. 10(1). 148–148. 148 indexed citations
16.
Yu, Chenchen, Yan Hu, Jinhong Duan, et al.. (2011). Novel Aptamer-Nanoparticle Bioconjugates Enhances Delivery of Anticancer Drug to MUC1-Positive Cancer Cells In Vitro. PLoS ONE. 6(9). e24077–e24077. 159 indexed citations
17.
Sun, Zhao, Zhe Liu, Jie Meng, et al.. (2011). Carbon Nanotubes Enhance Cytotoxicity Mediated by Human Lymphocytes In Vitro. PLoS ONE. 6(6). e21073–e21073. 41 indexed citations
18.
Sun, Zhao, Wei Wang, Rui Wang, et al.. (2010). Aluminum nanoparticles enhance anticancer immune response induced by tumor cell vaccine. Cancer Nanotechnology. 1(1-6). 63–69. 29 indexed citations
19.
Sun, Jianbo, et al.. (2009). Targeted Distribution of Bacterial Magnetosomes Isolated from <I>Magnetospirillum gryphiswaldense</I> MSR-1 in Healthy Sprague-Dawley Rats. Journal of Nanoscience and Nanotechnology. 9(3). 1881–1885. 34 indexed citations
20.
Meng, Jie, Jinhong Duan, Hua Kong, et al.. (2008). Carbon Nanotubes Conjugated to Tumor Lysate Protein Enhance the Efficacy of an Antitumor Immunotherapy. Small. 4(9). 1364–1370. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xujuan Yang Breakdown of academic impact, for papers by Sriram S. Shanmugavelandy Breakdown of academic impact, for papers by Larissa Yokota Rizzo Breakdown of academic impact, for papers by Jan‐Niklas May Breakdown of academic impact, for papers by Zhihao Han Breakdown of academic impact, for papers by Malathi Anantha Breakdown of academic impact, for papers by Jonathan P. May Breakdown of academic impact, for papers by Jungshan Chang Breakdown of academic impact, for papers by Qi Lu Breakdown of academic impact, for papers by Daniela Fraier
Rankless by CCL
2026